Sean Wu, VP of R&D, will be presenting our N-GlyFind™ technology at ICS2024 in Shanghai, China!
Lectenz Bio
Biotechnology Research
Athens, GA 510 followers
Lectenz Bio is a biotech company developing novel technologies and services for glycoscience.
About us
Lectenz Bio is developing novel products that employ our unique Lectenz® reagents and GlycoSense™ technology, to speed up and simplify the detection and discovery of disease biomarkers. These products enable targeting glycan biomarkers of clinical significance for investigation and leveraging them for advancing human health. Glycan-based biomarkers are particularly important for disease diagnosis and clinical treatment, yet their discovery and detection is challenging, due to the lack of glycan-specific reagents and tools. We are meeting this important need by developing innovative technologies in the glycosciences that will advance critical research and clinical applications. We are excited about helping to improve human health in this underexploited area. The company’s mission is to develop technologies that enable novel glycoscience applications, provide services that enhance glycan biomarker detection, and deliver tools that advance research and clinical applications.
- Website
-
https://www.lectenz.com
External link for Lectenz Bio
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Athens, GA
- Type
- Privately Held
- Founded
- 2007
- Specialties
- glycoprofiling, bioprocessing, biomanufacturing, glycans, complex carbohydrates, protein engineering, Lectenz, glycan analysis, high performance computing, protein engineering, glycomimetics, and computational chemistry
Locations
-
Primary
Get directions
Innovation Gateway
111 Riverbend Road
Athens, GA 30602, US
-
Get directions
San Diego Science Center
3030 Bunker Hill St
San Diego, CA 92109, US
Employees at Lectenz Bio
Updates
-
Lectenz Bio reposted this
Fantastic SialoGlyco 2024 conference in Lille 2 weeks ago! Thank you Guerardel Yann & organizing team for putting up such a smooth event. Personally, it was a very pleasant and productive experience to be on that side of the booth, many great conversations with just about everybody. Being back in my home town in France for Science, Friends and Family was certainly a one in a lifetime opportunity!
-
-
We're excited to be sponsoring SialoGlyco 2024 in Lille, France! Principal Scientist Sylvain Lehoux, PhD will give a presentation on the development and use of our Lectenz reagents on June 5. Stop by his poster and booth for even more information! #glycotime
-
-
We're attending #BIO2024 in San Diego! Schedule a meeting with us in the BIO Partnering System!
-
-
Lectenz Bio reposted this
At #BIO2024 ? Come to the NIH booth (825) on Tuesday, June 4th from 10:00-12:30 to see 10 innovative, peer-reviewed companies with non-dilutive funding pitch their incredible technologies! Andrew Gomperts of Hillhurst Biopharmaceuticals, Inc., Merika Koday, PhD and Mark Esposito, PhD of KayoThera, Roger Frechette and Cheri Ackerman of Concerto Biosciences, Karl Ruping of Tiba Biotech, Cuthbert Simpkins of Vivacelle Bio, Inc., Faraz A. Choudhury, Ph.D. of Immuto Scientific, Lori Yang of Lectenz Bio, Dean Petkanas of Kannalife Sciences, Inc., Bradley Keller of Accuronix Therapeutics, Inc., Zdravka Medarova and Tania Montgomery of TransCode Therapeutics, Inc., and Tarik S. of Extend Biosciences, Inc.
-
-
Lectenz Bio reposted this
NIH provides $1.3 Billion in funding for small business life science innovations each year. Stop by Booth 825 to learn about these companies, NIH funding, and programs that support biotech innovation at #BIO2024. Biotechnology Innovation Organization #SBIR #STTR
-
-
I'm excited to be attending #bio2024 in San Diego along with 45 cutting edge life science innovators, all of whom have built their products in part with non-dilutive funds given by one of the 24 Institutes of the #NIH. Of these, 30 will be with me at booth #825. These are all companies now looking for venture investment, #pharma partners, and/or strategic relationships -- and it's fair to say that having been selected for our Showcase program, they are all poised to improve the standard of care across their sectors. I'll share the names of these 30 below. If you'd like our team to put together introductions specific to your area of interest, please DM me. Regardless of what you may be looking for, there's a good chance one or more of these companies fits your checklist. AAVogen Accuronix Therapeutics, Inc. Biopico Systems INC Concerto Biosciences DermaXon Extend Biosciences, Inc. Lectenz Bio GSNO Therapeutics Hillhurst Biopharmaceuticals, Inc. Immuto Scientific Indee Labs Invivo Science International Inc Kannalife, Inc. KayoThera Lynthera Corporation Medosome Biotec Modality.AI Devine Biosystems Novoron Bioscience Pelagos Pharma Pirouette Medical Reveal Pharmaceuticals Sinopia Biosciences Sacromatrix Talus Bio Tiba Biotech TransCode Therapeutics, Inc. Ventrix Vivacelle Bio, Inc. Buel D. (a.k.a. Dan) Rodgers Bradley Keller John Collins Philippe Diaz Tarik S. Lori Yang Andrew Gomperts Faraz A. Choudhury, Ph.D. ryan P. Ayla Annac Dean Petkanas Merika Koday, PhD Jeff Yang David R. Craig, MBA Conor Cullinane, PhD
-
-
Due to popular demand, our spring enzyme sale has been extended through May 15! Use code enzymespring2024 at checkout to get 50% off all enzymes! #glycotime